Concepedia

Mary-Katherine Monahan

MM

4

Publications

255

Citations

4

H-Index

2001

Active since

Affiliations

Bayer (United States)(Current)

Mary-Katherine Monahan is an author at Bayer (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

2001–2005

4

Publications

4

A Scaleable Synthesis of BAY 43-9006:  A Potent Raf Kinase Inhibitor for the Treatment of Cancer

Donald Bankston, Jacques Dumas, Reina Natero et al. · Organic Process Research & Development · 2002 · 111 citations

, , +15

Metal triggered fluorescence sensing of citrate using a synthetic receptor

Larry A. Cabell, Michael D. Best, John J. Lavigne et al. · Journal of the Chemical Society Perkin Transactions 2 · 2001 · 86 citations

, , +16

Omega-carboxypyridyl substituted ureas as Raf kinase inhibitors

Uday R. Khire, Donald Bankston, J A Barbosa et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 44 citations · Full text

, , +5

Substituted indanylacetic acids as PPAR-α–γ activators

Derek Lowe, Neil Bifulco, William H. Bullock et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 14 citations · Full text

, , +3

Rows per page

1–4 of 4